Reclazepam
From Wikipedia, the free encyclopedia
|
Reclazepam
|
|
| Systematic (IUPAC) name | |
| 2-[7-chloro-5-(2-chlorophenyl)-2,3-dihydro -1,4-benzodiazepin-1-yl]-1,3-oxazol-4-one | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C18H13Cl2N3O2 |
| Mol. mass | 374.221 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Reclazepam is a drug which is a benzodiazepine derivative. It has sedative and anxiolytic effects similar to those produced by other benzodiazepine derivatives, and has a short duration of action.[1]
[edit] References
|
|||||||||||||||||||||||||||||

